作者:Ahmed M. Alafeefy、Saleh I Alqasoumi、Sami G. Abdel hamid、Kamal E. H. El-Tahir、Menshawy Mohamed、Mohamed E. Zain、Amani S. Awaad
DOI:10.3109/14756366.2013.795957
日期:2014.6.1
Thirty-one new theophylline derivatives have been synthesized and evaluated for their hypoglycemic activity. Compounds 24 (56% reduction) and 31 (57% reduction) showed better hypoglycemic activity than the standard drug glibenclamide which showed 52% reduction in serum glucose level. Compound 27 remarkably reduced serum glucose level by 53%. Ten compounds showed varying degrees of hypoglycemic activity ranging
已经合成了三十一种新的茶碱衍生物,并评估了它们的降血糖活性。化合物24(降低56%)和31(降低57%)显示出比标准药物glibenclamide更好的降血糖活性,标准药物glibenclamide降低了52%的血糖水平。化合物27显着降低血清葡萄糖水平53%。与标准药物相比,十种化合物显示出不同程度的降血糖活性,血清葡萄糖水平降低了20%至37%。芳香族酰胺官能团是这些茶碱降血糖衍生物的共同特征。但是,蒽环酰胺和/或脂族酰胺被证明是本系列中活性最低的化合物。